New targets for antibody therapy of pediatric B cell lymphomas.


Antibody therapy has become standard of care for adult B cell lymphoma patients. It is a potentially less toxic and more targeted approach for lymphoma therapy and should therefore be applied to treat pediatric B cell lymphoma patients as well. In pediatric lymphoma patients, however, clinical experience with monoclonal antibodies is very limited. This is… (More)
DOI: 10.1002/pbc.25193


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics